Brought to you by 
Ventana teams with Bayer on companion diagnostic for antibody-drug conjugate
11 Mar 2014
Executive Summary
In its fourth collaboration so far this month, and its second with a Big Pharma, Ventana Medical Systems Inc. (slide staining, automated tissue processing, and other anatomical pathology tools; part of Roche Diagnostics Corp.) is creating a companion diagnostic for one of Bayer HealthCare Pharmaceuticals AG’s anti-cancer antibody-drug conjugates.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com